Guess What Else is NOT a Top Priority of the FDA?
Answer: Monitoring postmarketing study commitments. The FDA lacks an effective system for monitoring postmarketing study commitments. See the latest OIG Report, dated June 2006.
Read More »Medicare Fraud 101
Medicare Fraud News, Breaking Headlines and Insight from the Qui Tam Perspective
Contact FormTag Archives: Clinical trial
Are Clinical Drug Studies Being Manipulated?
A pharmaceutical company can violate the false claims act by submitting false statements in connection with drug applications and other records to the United States…
Read More »